EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function - PubMed (original) (raw)
EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function
A D Hislop et al. J Immunol. 2001.
Abstract
EBV infection in humans induces CD8+ T cell memory to viral epitopes derived from both lytic and latent cycle Ags. We have analyzed the relationship between the phenotype and function of the memory pool of T cells specific for these Ags. Lytic epitope-specific populations were heterogeneous in terms of CD45RO/RA and CD28 expression, whereas latent epitope-specific populations were uniformly CD45RO+ and CD28+, consistent with the higher antigenic challenge from lytic epitopes driving some memory cells toward a CD45RA+, CD28- phenotype. However, both types of memory population showed immediate epitope-specific cytotoxicity and type 1 cytokine production in ex vivo assays. Cytotoxic function was not associated with preactivated T cells, as EBV-specific populations were negative for activation markers such as CD69 or CD38, nor could cytotoxic function be ascribed to CD27- or CD56+ subsets, as such cells were not detected in EBV-specific memory. Furthermore, cytotoxicity was not limited to CD45RA+ and/or CD28- fractions, but also was observed in CD45RO+, CD28+ populations in lytic and latent epitope-specific memory. Cytokine (IFN-gamma, TNF-alpha) responses, measured by intracytoplasmic staining after peptide stimulation, also were detectable in CD45RO+ and RA+ subsets as well as CD28+ and CD28- subsets. Of other markers that were heterogeneous in both lytic and latent epitope populations, CCR7 gave the best discrimination of functionality; thus, CCR7+ cells consistently failed to give an IFN-gamma or TNF-alpha response, whereas many CCR7- cells were responsive. Our data are consistent with effector functions having a broad distribution among phenotypically distinct subsets of "effector memory" cells that have lost the CCR7 marker.
Similar articles
- Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF. Tan LC, et al. Arthritis Res. 2000;2(2):154-64. doi: 10.1186/ar80. Epub 2000 Feb 7. Arthritis Res. 2000. PMID: 11062606 Free PMC article. - Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
Catalina MD, Sullivan JL, Brody RM, Luzuriaga K. Catalina MD, et al. J Immunol. 2002 Apr 15;168(8):4184-91. doi: 10.4049/jimmunol.168.8.4184. J Immunol. 2002. PMID: 11937579 - Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
Tomiyama H, Matsuda T, Takiguchi M. Tomiyama H, et al. J Immunol. 2002 Jun 1;168(11):5538-50. doi: 10.4049/jimmunol.168.11.5538. J Immunol. 2002. PMID: 12023349 - The immune system in extreme longevity.
Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M. Sansoni P, et al. Exp Gerontol. 2008 Feb;43(2):61-5. doi: 10.1016/j.exger.2007.06.008. Epub 2007 Jul 4. Exp Gerontol. 2008. PMID: 17870272 Review. - Immunodominant CD8 T cell response to Epstein-Barr virus.
Houssaint E, Saulquin X, Scotet E, Bonneville M. Houssaint E, et al. Biomed Pharmacother. 2001 Sep;55(7):373-80. doi: 10.1016/s0753-3322(01)00082-8. Biomed Pharmacother. 2001. PMID: 11669500 Review.
Cited by
- T cell memory in the context of persistent herpes viral infections.
Torti N, Oxenius A. Torti N, et al. Viruses. 2012 Jul;4(7):1116-43. doi: 10.3390/v4071116. Epub 2012 Jul 20. Viruses. 2012. PMID: 22852044 Free PMC article. Review. - Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
Cárdenas D, Vélez G, Orfao A, Herrera MV, Solano J, Olaya M, Uribe AM, Saavedra C, Duarte M, Rodríguez M, López M, Fiorentino S, Quijano S. Cárdenas D, et al. Clin Exp Immunol. 2015 Nov;182(2):173-83. doi: 10.1111/cei.12682. Epub 2015 Sep 11. Clin Exp Immunol. 2015. PMID: 26174440 Free PMC article. - Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot".
Bihl FK, Loggi E, Chisholm JV 3rd, Hewitt HS, Henry LM, Linde C, Suscovich TJ, Wong JT, Frahm N, Andreone P, Brander C. Bihl FK, et al. J Transl Med. 2005 May 11;3(1):20. doi: 10.1186/1479-5876-3-20. J Transl Med. 2005. PMID: 15888204 Free PMC article. - Loss of T cell responses following long-term cryopreservation.
Owen RE, Sinclair E, Emu B, Heitman JW, Hirschkorn DF, Epling CL, Tan QX, Custer B, Harris JM, Jacobson MA, McCune JM, Martin JN, Hecht FM, Deeks SG, Norris PJ. Owen RE, et al. J Immunol Methods. 2007 Sep 30;326(1-2):93-115. doi: 10.1016/j.jim.2007.07.012. Epub 2007 Aug 8. J Immunol Methods. 2007. PMID: 17707394 Free PMC article. - CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.
Ochsenbein AF, Riddell SR, Brown M, Corey L, Baerlocher GM, Lansdorp PM, Greenberg PD. Ochsenbein AF, et al. J Exp Med. 2004 Dec 6;200(11):1407-17. doi: 10.1084/jem.20040717. J Exp Med. 2004. PMID: 15583014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials